Objectives: To investigate the potential relationship between quinolone resistance and biofilm production in a collection of Salmonella enterica clinical isolates and in S. enterica serovar Typhimurium serial mutants with increasing resistance to ciprofloxacin.
Introduction
The levels of morbidity, mortality and burden of disease caused by Salmonella enterica are of substantial importance worldwide. Host susceptibility and infecting S. enterica serovar determine disease manifestation.
1,2 Serovars Typhimurium and Enteritidis are those most frequently reported as causing enterocolitis in humans. Fluoroquinolones and extended-spectrum cephalosporins are usually the treatment of choice for these infections. 2, 3 However, decreased susceptibility to both ciprofloxacin, which is associated with nalidixic acid resistance, and extended-spectrum cephalosporins is steadily increasing among Salmonella species. 4 -7 Consequently, the success of antimicrobial therapy may be compromised. Therefore, the mechanisms leading to resistance to such compounds need better understanding at a molecular level.
Quinolones inhibit the activity of the DNA gyrase and topoisomerase IV, two essential enzymes involved in the replication and transcription of DNA. Each enzyme is a heterotetramer composed of two identical A subunits (GyrA and ParC, respectively) and two identical B subunits (GyrB and ParE, respectively). 8, 9 Resistance to such compounds is attributable to mutations within the so-called quinolone resistance-determining regions (QRDRs) characterized in each subunit. Other chromosomally encoded mutations lead to a decreased intracellular accumulation of quinolone, either by means of the overexpression of efflux pump(s) (e.g. AcrAB/TolC) or by a decrease in the expression of porins. 10 Additionally, plasmid-encoded determinants decreasing fluoroquinolone susceptibility have also been characterized. 11 However, QRDR mutations and increased AcrAB/TolC are the most important and prevalent mechanisms. This pump has been reported to play a key role not only in conferring resistance to quinolones, but also in multidrug resistance (MDR), 12 -14 a term used for resistance to four or more antimicrobials in the case of non-typhoidal Samonella. 15 In Salmonella, AcrAB expression has been reported to be under the control of several regulators: the local repressor, AcrR, 16 and three transcriptional activators, MarA, belonging to the marRAB operon, 17 SoxS, belonging to the soxRS region 18 and RamA, repressed by the ramR gene. 19, 20 On the other hand, the ability to form a biofilm in response to unfavourable growth conditions is among the virulence properties described for S. enterica, since this phenotype contributes to conferring MDR and can help bacteria to survive in hostile or suboptimal environments. 21, 22 Curli fimbriae, also designated as thin aggregative fimbriae (Csg or Agf), and cellulose production have been well characterized as contributing to biofilm formation and the rdar morphotype (for red, dry and rough colony morphology). 23 -27 Recently, evidence showing an association between the acquisition of quinolone resistance and a decreased expression of virulence factors has been published. Several studies have revealed that ciprofloxacin-resistant S. enterica mutants show a decreased expression of invasion genes, particularly those encoded within the Salmonella pathogenicity island 1 (SPI-1), in association with decreased invasion ability in in vitro models. 14, 28, 29 In addition, a relationship has been found between in vitro biofilm formation and resistance to quinolones not only among uropathogenic Escherichia coli clinical strains, but also among Acinetobacter baumannii clinical isolates. In these studies, biofilm producers are significantly less frequently resistant to nalidixic acid or ciprofloxacin. 30, 31 In this study, a collection of 122 S. enterica clinical isolates, including nalidixic acid-susceptible and -resistant strains, was analysed to detect whether or not there is also a relationship between biofilm formation and quinolone resistance in S. enterica. Moreover, a fluoroquinolone-resistant Salmonella Typhimurium mutant was obtained from a susceptible and biofilm producer clinical isolate in an in vitro multistep selection procedure. Thus, the possible relationship between quinolone resistance acquisition and decreased biofilm production was also investigated in these mutants.
Materials and methods

Bacterial strains and selection of resistant mutants
A collection of 122 S. enterica clinical isolates was studied, 101 belonging to serotype Enteritidis, 19 to serovar Typhimurium, 1 to serovar Hadar and 1 to serovar Muenchen (Public Health Laboratory, Oviedo, Spain). Furthermore, one Salmonella Typhimurium clinical isolate, strain 59-wt, was independently recovered from a stool sample in the Department of Clinical Microbiology at the Hospital Clinic of Barcelona, Spain. Strain 59-wt was grown at 378C on MacConkey plates in the presence of ciprofloxacin in a multistep selection process to obtain strain 59-64, a ciprofloxacin-resistant mutant. Ciprofloxacin (Fluka, Steinheim, Germany) was only present in the agar plates during the selection procedures, starting at 0.007 mg/L (half of the MIC for 59-wt) and increasing 2-fold each step, until a maximum concentration of 64 mg/L was reached. Single colonies were selected at each step and named according to the ciprofloxacin concentration of selection (e.g. strain 59-0.015 was selected at a ciprofloxacin concentration of 0.015 mg/L). Certain intermediate mutants (59-0.015, 59-0.03, 59-0.06, 59-0.25, 59-2 and 59-16) were also included in the study. Furthermore, strain 59-64 was grown in the absence of ciprofloxacin for 50 consecutive steps to obtain strain 59-rev.
Biofilm production
Biofilm production was assessed according to a previously described protocol with some modifications. 32 Briefly, overnight bacterial cultures grown at 378C with shaking, adjusted to the same optical density (OD) at 600 nm, were used to inoculate 1 mL of Luria-Bertani (LB) broth (without NaCl) in small polystyrene tubes (1/100 dilution). Incubation followed at 288C for 48 h without shaking. The medium was then discarded and the tubes stained with 1.5 mL of 1% Crystal Violet for 5 min. Finally, they were washed three times with water and left to dry. An isolate was categorized as a biofilm producer when a violet ring was visible in the tube. When biofilm production was determined for strain 59-wt and the derivative mutants, the Crystal Violet ring was dissolved with 96% ethanol in order to measure the OD at 620 nm in an automatic spectrophotometer (Anthos Reader 2001, Innogenetics, Spain). This assay was carried out in triplicate.
Congo Red and calcofluor phenotype assays
Strains were grown overnight in LB medium at 378C with shaking. Cultures were adjusted to the same OD at 600 nm and then 10 mL was spotted onto LB plates (without NaCl) containing 40 mg/mL Congo Red and 20 mg/mL Coomassie Brilliant Blue or 400 mg/mL calcofluor. The drops were allowed to dry prior to incubation of the plates at 288C for 48 h. The rdar morphotype was assessed on Congo Red plates, since absorption of this dye is indicative of curli and cellulose production. 33 A fluorescence of colonies under UV light indicated calcofluor binding, which is mainly indicative of cellulose production. 33 
Susceptibility testing
The MICs of ciprofloxacin, norfloxacin, nalidixic acid, chloramphenicol, tetracycline, erythromycin, amikacin, amoxicillin, ceftriaxone and cefoxitin were determined by Etest (AB Biodisk) according to the manufacturer's recommendations. The broth microdilution method was used to evaluate the MICs of ciprofloxacin, norfloxacin and nalidixic acid when maximum Etest values were reached. The MICs were determined according to CLSI guidelines. 34 The MICs of quinolones, tetracycline and erythromycin were also determined in the presence of 20 mg/mL of the efflux pump inhibitor phenyl-arginine-b-naphthylamide (PAbN) (Sigma-Aldrich, St Louis, MO, USA) in Mueller Hinton (MH) plates.
Detection of mutations within the QRDRs and regulatory loci
Amplification of the QRDRs of gyrA, gyrB, parC and parE as well as the soxRS, marRAB, acrR and ramR MDR regulatory loci was performed by PCR amplification as previously described. 14 The PCR products were recovered and sent to Macrogen Inc. (Seoul, South Korea) for sequencing to allow comparison with the genome of Salmonella Typhimurium LT2 as the reference strain (RefSeq NC_003197.1).
Cell envelope protein gel electrophoresis
Protein samples were obtained as previously reported by our group. 14 Bacterial pellets from overnight cultures were rinsed and resuspended in chilled Tris-Mg buffer. Samples were centrifuged after sonication, and the supernatant was centrifuged again. Pellets were finally frozen at Fà brega et al. 2208C . A 12% SDS-PAGE was run and the protein bands of interest were recovered and sent to the Parc Cientific of Barcelona (Barcelona, Spain), where the proteins were characterized through matrix-assisted laser desorption ionization-time of flight analysis.
Western blotting
Western blot detection was performed as previously reported.
14 Cell envelope proteins were extracted and resuspended in 1× PBS. Amounts of 10 mg of each protein sample were loaded onto an 8% SDS-PAGE and transferred onto a nitrocellulose membrane on ice. The membranes were appropriately treated and incubated overnight at 48C with the primary antibody against TolC diluted 1/500. Secondary antibody, anti-rabbit IgG, diluted 1/2000, was added for 1 h of incubation. Finally, the membranes were washed again and processed for chemiluminescence detection.
RNA extraction and real-time PCR
Four independent RNA extractions were carried out following the previously described protocol.
14 Exponential phase cultures were grown in LB at 378C with shaking until the OD values at 600 nm were similar and between 0.5 and 0.6. For the stationary phase analysis, subcultures were grown overnight in LB in the absence of NaCl at 288C and without shaking.
cDNA synthesis and RT-PCR were performed as described elsewhere. 35 The genes selected for analysis in exponential phase cultures were acrR, soxS, marA, ramA and acrF, whereas csgB, csgD, adrA and bapA were tested in stationary phase cultures. Relative gene expression was evaluated using the 2 2DDCT method, and the 16S rRNA gene was used as an internal control to normalize the transcriptional levels. Each RNA sample was tested in triplicate. A total of four independent assays were performed. The primers used are reported in Table 1 .
Ciprofloxacin accumulation
The intracellular accumulation of ciprofloxacin was determined according to the protocol previously reported by our group and adapted from that described by Mortimer and Piddock. 35, 36 Briefly, bacteria were grown in LB to late-log phase at 378C with shaking (OD at 600 nm¼ 0.8 -0.9) and a pellet was obtained and washed in PBS. A final concentration of 10 mg/L of ciprofloxacin was added and aliquots of 500 mL were taken at different time intervals for 10 min. After timepoint 5, 100 mM carbonyl cyanide m-chlorophenylhydrazone (CCCP), an energy uncoupler, was added to the reaction. Aliquots were washed and lysed overnight in 0.1 M glycine hydrochloride (pH 3.0) before fluorescence was measured. A standard curve in 0.1 M glycine hydrochloride (pH 3.0) was tested to infer the concentration of the drug.
Fitness
Strains were incubated overnight in LB at 378C with shaking and then diluted to a similar OD at 600 nm. A 1/100 dilution in fresh LB broth followed and bacterial growth was allowed with shaking (540 rpm) in sterile 96-well microplates and assessed in an iEMS Multiskan MF Reader (Thermo Fisher Scientific). Bacterial curves were calculated for both conditions: 378C in LB and 288C in LB without NaCl. OD at 620 nm was determined every 15 min for 24 h. Four independent assays were performed for each strain and standard deviation agreed to within 10%.
Statistical analysis
Normal distribution was checked in order to apply parametric or nonparametric tests. When a normal distribution was found, differences between groups were detected by applying parametric tests: ANOVA (with contrasts) when more than two strains were compared or a paired t-test when comparing only two strains. Otherwise, Kruskal -Wallis and Mann -Whitney tests were applied to detect significant differences. Categorical data were compared using the x 2 test. All statistical analyses were performed using IBM SPSS Statistics soft- 
Results
Biofilm production and nalidixic acid susceptibility among clinical strains
The in vitro capacity to form biofilm was studied among 122 S. enterica clinical isolates by testing the ability to form a visible ring. Sixty-seven (55%) isolates were biofilm positive and 55 (45%) were biofilm negative. Among the 101 Salmonella Enteritidis isolates, 52 (51%) were positive for biofilm and 49 (49%) were negative. Most of the 19 Salmonella Typhimurium isolates (n ¼ 14) were positive for biofilm formation (74% versus 26%). Finally, the only isolate belonging to serovar Muenchen Concerning the quinolone resistance phenotype of these 122 strains, 82 (67%) isolates were susceptible to nalidixic acid (MIC , 16 mg/L), whereas the other 40 (33%) were resistant (MIC ≥64 mg/L). When the capacity to form biofilm was compared with nalidixic acid susceptibility, a relationship, albeit not significant, was observed between the two characteristics: susceptible strains were more frequently found to form biofilm than the resistant isolates (74.5% versus 25.4%, P ¼ 0.054).
Acquisition of fluoroquinolone resistance, strain 59-64
In order to study the possible relationship between the acquisition of quinolone resistance and decreased biofilm production, a quinolone-susceptible and biofilm-producing Salmonella Typhimurium clinical isolate, strain 59-wt, was chosen and its high-level fluoroquinolone resistant mutant, strain 59-64, was obtained in vitro by exposure to increasing concentrations of ciprofloxacin. Intermediate mutants were also selected and studied (strains 59-0.015, 59-0.03, 59-0.06, 59-0.25, 59-2 and 59-16). Regarding all these strains, sequencing of the QRDRs of the four target genes (gyrA, gyrB, parC and parE) was performed, as was the MIC determination for several quinolones (ciprofloxacin, norfloxacin and nalidixic acid) in the absence and presence of PAbN (Table 2) .
Strain 59-wt showed an MIC of ciprofloxacin of 0.012 mg/L that rose to 256 mg/L in the high-level resistant mutant 59-64. A total of five QRDR mutations were found in 59-64, which were gradually acquired: strain 59-0.03 showed a substitution in GyrB (E466D), strain 59-2 acquired two amino acid changes, one in GyrA (S83Y) and another in ParC (S80R), and finally, strain 59-64 revealed two further modifications, one in GyrA (D87G) and one in ParC (F115S). Increments in the MICs of the three quinolones tested were observed in these three strains (4-to 16-fold for ciprofloxacin, 4-to 8-fold for norfloxacin and 6-to 64-for nalidixic acid), and attributed to the mutations described, since a parallel increase in these MICs was also observed in the presence of PAbN. There was only one exception, strain 59-64, which showed no increase concerning the MIC of nalidixic acid (8192 mg/L). Otherwise, strains 59-0.06, 59-0.25 and 59-16 did not acquire any QRDR mutation but showed increasing MICs of quinolones. Strain 59-16 displayed the largest increments, 5.3-fold for ciprofloxacin and 6-fold for norfloxacin. Since this strain showed the same MIC values in the presence of PAbN as 59-2, the previous resistant mutant, these increments are likely to be the result of the overexpression of a PAbN-susceptible efflux pump(s). Intriguingly, in comparison with 59-2, the two most resistant strains, 59-16 and 59-64, showed no change in the already high MIC of nalidixic acid (8192 mg/L) ( Table 2) .
Finally, strain 59-64 was grown on agar plates in the absence of ciprofloxacin in order to obtain a strain with a reverted phenotype. However, after 50 consecutive steps, strain 59-rev was selected and analysed, with no difference in the resistance phenotype being detected in comparison to 59-64.
MDR
The occurrence of an MDR phenotype is usually concomitant with the acquisition of fluoroquinolone resistance.
37,38 Thus, we determined the MICs of several unrelated antibiotics (chloramphenicol, tetracycline, erythromycin, amikacin, amoxicillin, ceftriaxone, cefoxitin) for strains 59-wt and 59-64. The results showed an increase ranging from 4-to 32-fold in the MICs of all these antibiotics in strain 59-64 when compared with the susceptible isolate. There were only three exceptions: chloramphenicol, amoxicillin and amikacin. Strain 59-wt was already resistant to chloramphenicol and amoxicillin (.256 mg/L), while no increase in the MIC of amikacin was found (1.5 mg/L) ( Table 3) . Furthermore, the MICs of tetracycline, erythromycin, ceftriaxone and cefoxitin were also determined for all intermediate mutants.
The results showed two consecutive 1.5-to 3-fold increments for strains 59-0.06 and 59-0.25, and a more noteworthy 2-to 8-fold increase in the case of 59-16. Moreover, the MICs of tetracycline and erythromycin were also determined in the presence of PAbN and revealed that increased efflux inhibition was detected in strain 59-0.06, higher inhibition values were seen for 59-0.25, and maximal inhibition was achieved in 59-16 and 59-64. Fà brega et al.
Altogether, these findings suggest that a broad-spectrum mechanism such as increased efflux is involved in strains 59-0.06, 59-0.25 and particularly 59-16, as mentioned above.
Analysis of the MDR regulatory genes
Mutations within the regulatory genes that lead to increased AcrAB transcription have been reported to trigger both quinolone resistance and MDR phenotypes. 16, 20, 39, 40 Thus, sequencing of the acrR, soxRS, marRAB and ramR regulatory loci and their corresponding promoters was performed for 59-wt and 59-64. The sequencing results revealed the acquisition of two mutations. The first was a 1 bp nucleotide deletion (adenine at position 139) within acrA leading to a frameshift mutation in the amino acid at position 47 in both the 59-wt and 59-64 strains. This mutation would cause a premature stop codon to appear at position 72, triggering a truncated protein. The second mutation detected was a point mutation within the ramA promoter in the mutant 59-64 when compared with 59-wt. Previous studies have characterized different strains (e.g. BN10055 20 and LTL 41 ) carrying deletions affecting the putative RamR-binding sites and have associated them with increased expression of the ramA gene.
Similarly, the mutation detected here is located within one of these binding sites and is assumed to impair basal ramA repression (Figure 1) . A parametric test consistently detected significantly increased expression (.12-fold) of the ramA gene by RT-PCR analysis in the resistant mutant 59-64 in comparison with 59-wt when assessing exponential phase cultures (P ¼ 0.014596) (data not shown).
Expression analysis of AcrAB, TolC and AcrEF
Several methodologies were carried out to study the increased expression and hence putative involvement of efflux-related proteins. SDS-PAGE analysis was performed using a cell envelope protein extract from strains 59-wt and 59-64. In agreement with the acrA frameshift mutation, the bands corresponding to AcrB and AcrA virtually showed the same reduced expression levels in the two strains in comparison with the positive control strain 50-64, a Salmonella Typhimurium mutant previously reported to overexpress AcrAB 14 ( Figure 2a ). Western blotting using antibodies against TolC was then performed. The results revealed an increased TolC expression in 59-64 when compared with the basal levels of 59-wt (Figure 2b) . Quinolone resistance, biofilm production and fitness
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JAC Several studies performed with E. coli or Salmonella Typhimurium mutants that do not express AcrAB have shown an up-regulation of the alternative efflux pump AcrEF that may compensate the absence of AcrAB. 42 -44 Therefore, we studied the possibility that AcrEF may act in conjunction with TolC and lead to the MDR phenotype of 59-64. acrF expression was evaluated by RT -PCR analysis of the exponential growth phase of strains 59-wt and 59-64. However, the results showed no change among these strains, suggesting no role in the resistance phenotype for AcrEF (data not shown).
Ciprofloxacin accumulation
In order to accurately evaluate whether or not increased efflux was selected during the resistance procedure, particularly in the case of the mutant 59-16, the intracellular accumulation of ciprofloxacin was measured. The strains tested included 59-wt, 59-2, 59-16 and 59-64. On comparing the results with 59-wt, a decrease in the accumulation levels was observed for 59-2, followed by a consecutive reduction for 59-16. These low levels of intracellular ciprofloxacin were maintained in 59-64. In order to confirm the contribution of efflux to the resistance phenotype, the energy uncoupler CCCP was added to the samples, leading to a substantial increase in ciprofloxacin accumulation in all strains, despite the values of 59-16 and 59-64 not reaching those observed for 59-wt and 59-2 ( Figure 3) . Thus, increased efflux seems to have been acquired at several steps in the resistance procedure. The first step may be the result of the cumulative effects in the mutants previously selected to 59-2 (likely to be 59-0.06 and 59-0.25 as mentioned above), and the second step is related to 59-16. Nonetheless, the contribution of efflux seems to be equal in both steps.
Biofilm formation and related phenotypes
Biofilm production was determined for 59-wt and all the derivative mutants. The results showed a progressive decrease in this virulence trait that occurred inversely to the resistance values observed. Significant differences were determined applying nonparametric tests. The most significant and representative decrease was observed between 59-2 and 59-16 (P¼0.000032), leading to a 3.6-fold reduction (Figure 4a) . To further study which of the elements involved in biofilm formation had impaired expression, production of curli fibres and cellulose was tested through several approaches.
First, colony morphology was tested in all strains on Congo Red plates at 288C. This dye has been reported to be indicative of curli and cellulose production. 33 The results showed a pattern similar to that observed for biofilm production: a progressive reduction in the rdar morphotype with a more important decrease for strains 59-16 and 59-64, which were unable to produce this trait (Figure 4b) . Second, the phenotype of all strains after growth on plates with calcofluor was analysed. This fluorochrome has been reported to be primarily indicative of cellulose production. 33 However, in this situation no difference was observed under UV light between all the strains. These results suggested an impaired expression of curli fibres but no change in cellulose production.
Expression of biofilm-related genes
Finally, expression of the genes involved in biofilm production was assessed by the RT-PCR analysis of overnight cultures of 59-wt, 59-2, 59-16 and 59-64, since the most important decrease in biofilm formation was seen for 59-16. The genes tested were: csgB, nucleator and minor subunit of curli fibres, 27 adrA, posttranscriptional activator of cellulose biosynthesis, 45 bapA, large surface adhesin, 45 and csgD, master regulator of biofilm. 46 The most consistent and reproducible results were obtained for the csgB gene, which were analysed using parametric tests. Initially, a 2.2-fold reduction was observed for 59-2 in comparison with 59-wt, albeit without significance. Nonetheless, a major and statistically significant decrease of 23-fold was seen for 59-16 when compared with 59-2 (P ¼ 0.000081) ( Figure 5 ). These results suggest that the decrease in biofilm production and the rdar morphotype observed in 59-16 and 59-64 are attributable to reduced csgB expression.
Fitness
Bacterial growth was evaluated for 59-wt and all mutant strains by measuring the OD at 620 nm every 15 min for 24 h at 288C and Fà brega et al.
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. On comparing the growth curves, a significant difference was detected between the two most resistant mutants, 59-16 and 59-64, and the rest of the strains. The resistant mutants showed a diminished ability to grow since a longer lag phase was observed before the exponential growth. These differences were observed at the two temperatures tested. Once bacteria reached the stationary phase, the differences between all the strains disappeared ( Figure 6 ). Moreover, the specific growth rate (m) was calculated according to m ¼ (lnN -lnN 0 )/(t -t 0 ). The resulting data obtained for both temperatures, 288C and 378C, were analysed applying non-parametric or parametric tests, respectively. Significant differences were detected between 59-2 and 59-16 in both conditions [P ¼ 0.021 (288C) and P ¼ 0.000004 (378C)].
Discussion
In this study, we evaluated the biofilm-forming ability of a collection of 122 S. enterica clinical isolates. Among these, 82 strains were reported to be nalidixic-acid susceptible, whereas the remaining 40 strains were resistant. The results are in agreement with those of previous studies performed by our group and showed a relationship between nalidixic acid susceptibility and biofilm production, with susceptible strains more frequently producing biofilm than resistant strains. Quinolone resistance, biofilm production and fitness
In order to better understand this relationship, a quinolonesusceptible Salmonella Typhimurium clinical isolate, 59-wt, was selected to obtain in vitro mutants with increasing MICs to quinolones. Strain 59-64 was the most resistant mutant, displaying a ciprofloxacin MIC of 256 mg/L. The mechanisms of quinolone resistance acquisition were studied first. Strain 59-64 acquired up to five QRDR mutations, three leading to well-described amino acid substitutions at the most frequently affected positions (S83Y and D87G in GyrA and S80R in ParC, in strains 59-2 and 59-64). 47 -49 Substitutions within GyrB and ParE have been reported, although their prevalence is much less frequent and they have sometimes been related to a minor contribution to resistance. 50, 51 In this study, the first amino acid modification, which has only recently been reported, 29 was detected in GyrB (E466D) in strain 59-0.03. Although the replacement residue did not change the functional group, the MICs of the three quinolones tested concomitantly increased. Otherwise, the fifth substitution (59-64) occurred in ParC (F115S) and has not been previously described. However, its contribution to the resistance phenotype cannot be completely elucidated since it was acquired simultaneously with the second amino acid substitution in GyrA.
Increased efflux in S. enterica (i.e. AcrAB overexpression) has been reported as usually representing the first step in the process of quinolone resistance acquisition, whereas QRDR mutations as well as enhanced efflux activity are acquired in following steps. 13, 14, 47, 52 In the present study, however, the first step (59-0.03) was explained by the acquisition of a mutation in the gyrB gene in strain 59-0.03. In contrast, the ciprofloxacin accumulation results indicated that increased efflux was acquired later and in at least two separate steps, 59-2 and 59-16. Since the increments in resistance observed in strain 59-2 are likely to be the result of two target gene mutations, this increased efflux may have been acquired before, in strains 59-0.06 and 59-0.25, according to the MIC values of both quinolones and other unrelated antibiotics observed in the absence and presence of PAbN. Of note, no further increase in the MIC of nalidixic acid was observed in the two most resistant strains (59-16 and 59-64), even though the GyrA amino acid substitution D87G (59-64) is associated with a .4-fold increase in the MICs of these quinolones. 13, 14, 47 These results suggest the existence of a plateau in the levels of resistance to nalidixic acid (MIC of 8192 and 128 mg/L in the absence and presence of PAbN, respectively). Similar results related to an upper limit to drug resistance have been reported in E. coli.
53
This study has also shown that MDR concurred with the fluoroquinolone resistance phenotype. The wide range of exportable substrates shown by 59-64 is similar to that shown by AcrABTolC. Nevertheless, our results revealed no overexpression of this major efflux pump attributable to a frameshift deletion within acrA in both the 59-wt and 59-64 strains. Despite the reported difficulty in selecting ciprofloxacin-resistant mutants in the absence of acrB, 54 strain 59-64 displayed an MDR phenotype comparable to that reported for mutants overexpressing AcrAB. 14, 29 Evidence that other efflux systems are likely to be involved in conferring quinolone resistance and MDR phenotypes have previously been reported. 14, 29, 52 Among the alternatives, several studies have revealed that after acrB inactivation, in either E. coli or Salmonella Typhimurium strains, overexpression of acrEF can be detected and may relay the usual AcrAB overexpression. 42 -44 However, the results obtained in this study ruled out a possible acrF overexpression in 59-64. Even though AcrAB does not play a role in the present study, on analysing the MDR regulatory genes, which usually activate this major efflux pump, the findings revealed increased expression of the ramA gene attributable to a mutation within one of the two RamR-binding sites located in its own promoter. Thus, at least one efflux system involved in conferring these resistance phenotypes, likely to be acting in conjunction with TolC, is under the positive control of RamA, although it has yet to be characterized.
Finally, biofilm production was evaluated for strain 59-wt and its derivative mutants in order to further study whether the acquisition of quinolone resistance was related to a decrease in biofilm formation. Production of biofilm was shown to progressively diminish as far as quinolone resistance increased, although a more significant reduction was observed for the two most resistant strains, 59-16 and 59-64. Similarly, a parallel decrease was observed in terms of the rdar morphotype. Both features could be explained by the decreased expression of the csgB gene, more importantly detected in these two strains.
Several studies have focused on the putative relationship between antimicrobial resistance and virulence. Several approaches need to be considered. First, the selection of fluoroquinolone resistance usually correlates with impaired fitness, 14, 29, 55 this phenotype being attributed to the acquisition of mutations leading to increased efflux. 56 Second, this resistance phenotype, supported by target gene mutations, AcrAB overexpression and reduced fitness, has been associated with a decreased expression of virulence factors and a consequent reduction in in vitro invasiveness. 14, 29, 57 Third, the inactivation of efflux pump components, such as acrB and particularly tolC, leads to impaired virulence, including in vitro invasion and in vivo colonization. 58 -60 Moreover, both inactivation and high overexpression of the ramA gene, and consequently of acrAB, leads to impaired expression of virulence determinants, reduced macrophage survival and diminished virulence in in vivo models. 61 Concerning biofilm production, individual inactivation of both tolC and acrB triggers a reduction in biofilm formation. 32 In this study, we report that an increasing quinolone resistance phenotype, combining target gene mutations and increased efflux, was inversely related to a reduction in formation of biofilm and the rdar morphotype as well as diminished expression of the csgB gene. The results suggest two stages, the initial stage of which would be progressively acquired and represent the cumulative effects of mutations acquired in several strains (from 59-wt to 59-2). In contrast, the second stage would be more drastic (strains 59-16 and 59-64). These findings could be explained by the type of mutations acquired in 59-16. The reduced biofilm production detected in this strain may appear as a consequence of the noteworthy increased efflux, a property that may also explain the impaired fitness observed. As previously reported, an appropriate production of efflux systems seems to play a key role in determining the expression of virulence properties, since both absence and overexpression appear to be detrimental for virulence. 58 -60 The diminished virulence observed, in terms of biofilm production, may also reflect bacterial adaptation to the increased energy consumption, supported by increased efflux, by turning off such virulence properties that are dispensable for bacterial survival. Further work is needed in order to determine the efflux pump(s) involved in the resistance phenotype, thereby allowing a more precise evaluation of the relationship between quinolone resistance and biofilm formation.
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